Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up

Natalizumab inhibits the transmigration of immune cells across the blood-brain barrier thus inhibiting inflammation in the central nervous system. Generally, this blockade at the blood-brain barrier has significant influence on the circulating lymphocytes. Up to date, only short-term data on periphe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Maxi, Haase, Rocco, Proschmann, Undine, Ziemssen, Tjalf, Akgün, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292961/
https://www.ncbi.nlm.nih.gov/pubmed/30581413
http://dx.doi.org/10.3389/fneur.2018.01071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292961/
https://www.ncbi.nlm.nih.gov/pubmed/30581413
http://dx.doi.org/10.3389/fneur.2018.01071

Ejemplares similares